EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Casiopeina III-ia: A Copper Compound with Potential Use for Treatment of Infections Caused by Leishmania mexicana

José Delgado-Domínguez, Lizet Mejía-Camacho, Lisset Torres-Martínez, Jaime Zamora-Chimal, Rocely Cervantes-Sarabia, Adrián Espinoza-Guillen, Lena Ruiz-Azuara, Ingeborg Becker

Chemotherapy · 2024

DOI: 10.1159/000538360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemotherapy, 2024. Verfasst von José Delgado-Domínguez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico. Hauptthemen laut MEDLINE: Leishmania mexicana, Leishmaniasis, Cutaneous, Reactive Oxygen Species, Copper. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Casiopeina III-ia (CasIII-ia) is a mixed chelate copper (II) compound capable of interacting with free radicals generated in the respiratory chain through redox reactions, producing toxic reactive oxygen species (ROS) that compromise the viability of cancer cells, bacteria and protozoa. Due to its remarkable effect on protozoa, this study evaluated the effect of CasIII-ia on Leishmania mexicana amastigotes and its potential use as a treatment for cutaneous leishmaniasis in the murine model.

Methods

We analyzed the leishmanicidal effect of CasIII-ia on L. mexicana amastigotes and on their survival in bone marrow-derived macrophages. Furthermore, we evaluated the production of ROS in treated parasites and the efficacy of CasIII-ia in the treatment of mice infected with L. mexicana.

Results

Our results show that CasIII-ia reduces parasite viability in a dose-dependent manner that correlates with increased ROS production. A decrease in the size of footpad lesions and in parasite loads was observed in infected mice treated with the intraperitoneal administration of CasIII-ia.

Conclusions

We propose CasIII-ia as a potential drug for the treatment of cutaneous leishmaniasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmania mexicanaLeishmaniasis, CutaneousReactive Oxygen SpeciesCopperAntiprotozoal AgentsMice, Inbred BALB CAnimalsMiceMacrophagesFemaleDisease Models, Animal

Stichwörter der Autor:innen

Bone marrow-derived macrophagesCasiopeina III-iaCopperLeishmania mexicanaReactive oxygen species

Substanzen

Reactive Oxygen SpeciesCopperAntiprotozoal Agents

Autor:innen und Institutionen

  • Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Departamento de Química Inorgánica y Nuclear, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City, Mexico.

Zitieren

APA

Delgado-Domínguez, J., Mejía-Camacho, L., Torres-Martínez, L., Zamora-Chimal, J., Cervantes-Sarabia, R., Espinoza-Guillen, A., Ruiz-Azuara, L., & Becker, I. (2024). Casiopeina III-ia: A Copper Compound with Potential Use for Treatment of Infections Caused by Leishmania mexicana. Chemotherapy. https://doi.org/10.1159/000538360

Vancouver

Delgado-Domínguez J, Mejía-Camacho L, Torres-Martínez L, Zamora-Chimal J, Cervantes-Sarabia R, Espinoza-Guillen A, et al. Casiopeina III-ia: A Copper Compound with Potential Use for Treatment of Infections Caused by Leishmania mexicana. Chemotherapy. 2024. doi:10.1159/000538360

BibTeX
@article{DelgadoDomnguez2024,
  author = {Delgado-Domínguez, José and Mejía-Camacho, Lizet and Torres-Martínez, Lisset and Zamora-Chimal, Jaime and Cervantes-Sarabia, Rocely and Espinoza-Guillen, Adrián and Ruiz-Azuara, Lena and Becker, Ingeborg},
  title = {Casiopeina III-ia: A Copper Compound with Potential Use for Treatment of Infections Caused by Leishmania mexicana},
  journal = {Chemotherapy},
  year = {2024},
  doi = {10.1159/000538360}
}
Kostenlos starten →